![]() |
breseq version 0.24 revision cd15a9d216e1
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Marginal read alignment evidence... | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
seq id | position | change | freq | score | reads | annotation | genes | product | ||
* | REL606 | 2,768,203 | 0 | G→T | 13.4% | 13.7 ‑13.7 ‑0.0 | 104 | intergenic (‑5/+45) | ygbE/cysC | conserved inner membrane protein/adenylylsulfate kinase |
* | REL606 | 2,735,719 | 0 | C→G | 13.7% | 9.8 ‑23.4 0.0 | 126 | 1336 | ascF | fused cellobiose/arbutin/salicin‑specific PTS enzymes: IIB component/IC component |
* | REL606 | 2,735,500 | 0 | A→G | 13.9% | 8.5 ‑15.6 0.0 | 97 | 1117 | ascF | fused cellobiose/arbutin/salicin‑specific PTS enzymes: IIB component/IC component |
* | REL606 | 3,893,550 | 1 | .→G | 4.8% | 7.4 0.0 ‑0.1 | 62 | intergenic (+5/‑51) | kup/insJ‑5 | potassium transporter/IS150 hypothetical protein |
* | REL606 | 2,732,670 | 0 | C→A | 11.7% | 6.1 ‑17.2 0.0 | 141 | 296 | hydN | formate dehydrogenase‑H, [4Fe‑4S] ferredoxin subunit |
* | REL606 | 2,729,224 | 0 | G→T | 13.0% | 5.6 ‑13.9 0.0 | 95 | 453 | ygbD | nitric oxide reductase |
* | REL606 | 2,735,985 | 0 | A→G | 10.7% | 4.8 ‑14.8 0.0 | 107 | 136 | ascB | cryptic 6‑phospho‑beta‑glucosidase |
* | REL606 | 2,760,913 | 0 | A→G | 10.5% | 4.7 ‑15.7 0.0 | 97 | 952 | ygbN | predicted transporter |
* | REL606 | 179,945 | 1 | .→G | 4.8% | 3.9 ‑1.4 0.0 | 63 | coding (522/624 nt) | yadS | conserved inner membrane protein |
* | REL606 | 2,735,994 | 0 | C→G | 6.6% | 3.2 ‑9.6 0.0 | 105 | 145 | ascB | cryptic 6‑phospho‑beta‑glucosidase |
* | REL606 | 2,730,188 | 0 | G→A | 10.2% | 3.1 ‑10.6 0.0 | 97 | 2098 | hypF | carbamoyl phosphate phosphatase and maturation protein for [NiFe] hydrogenases |
* | REL606 | 2,728,648 | 0 | C→A | 6.1% | 2.7 ‑6.6 0.0 | 105 | 1313 | norV | anaerobic nitric oxide reductase flavorubredoxin |
* | REL606 | 2,735,984 | 1 | .→A | 1.9% | 2.6 ‑2.5 ‑0.1 | 103 | coding (135/1425 nt) | ascB | cryptic 6‑phospho‑beta‑glucosidase |
* | REL606 | 2,745,080 | 0 | A→T | 7.7% | 1.9 ‑10.4 0.0 | 91 | 216 | hycA | regulator of the transcriptional regulator FhlA |
* | REL606 | 15,389 | 0 | A→C | 5.3% | 1.3 ‑6.6 0.0 | 131 | intergenic (+93/‑54) | dnaJ/insL‑1 | chaperone Hsp40, co‑chaperone with DnaK/IS186 hypothetical protein |
* | REL606 | 2,735,117 | 1 | .→G | 2.5% | 1.2 ‑2.1 ‑0.0 | 81 | coding (734/1458 nt) | ascF | fused cellobiose/arbutin/salicin‑specific PTS enzymes: IIB component/IC component |
* | REL606 | 2,774,997 | 0 | G→T | 100.0% | 0.4 | 7 | 316 | insK‑3 | IS150 putative transposase |
* | REL606 | 2,735,429 | 1 | .→G | 2.8% | 0.3 ‑2.1 ‑0.0 | 71 | coding (1046/1458 nt) | ascF | fused cellobiose/arbutin/salicin‑specific PTS enzymes: IIB component/IC component |
* | REL606 | 2,763,358 | 0 | A→G | 6.7% | 0.3 ‑11.2 0.0 | 139 | 257 | nlpD | predicted outer membrane lipoprotein |
* | REL606 | 3,554,981 | 0 | A→G | 100.0% | 0.3 | 1 | intergenic (+161/‑85) | yrhC/yhhI | b4552; predicted protein fragment/predicted transposase |
* | REL606 | 3,774,124 | 0 | G→T | 8.0% | 0.3 ‑8.5 0.0 | 90 | 848 | yicJ | predicted transporter |
* | REL606 | 1,499,100 | 0 | A→G | 100.0% | 0.2 | 3 | 1017 | ECB_01413 | conserved hypothetical protein |
* | REL606 | 2,758,137 | 1 | .→C | 2.6% | 0.2 ‑1.7 0.0 | 76 | coding (943/1263 nt) | ygbK | hypothetical protein |
* | REL606 | 1,607,774 | 0 | T→G | 100.0% | 0.1 | 2 | 159 | ECB_01510 | putative tail component of prophage |
* | REL606 | 1,607,775 | 0 | A→T | 100.0% | 0.1 | 2 | 158 | ECB_01510 | putative tail component of prophage |
* | REL606 | 1,607,786 | 0 | C→A | 100.0% | 0.1 | 2 | 147 | ECB_01510 | putative tail component of prophage |
* | REL606 | 2,729,228 | 0 | G→T | 9.5% | 0.1 ‑11.1 0.0 | 98 | 457 | ygbD | nitric oxide reductase |
* | REL606 | 2,774,998 | 0 | C→T | 100.0% | 0.1 | 7 | 315 | insK‑3 | IS150 putative transposase |
* | REL606 | 2,775,474 | 0 | G→T | 100.0% | 0.1 | 5 | 357 | insJ‑3 | IS150 hypothetical protein |
* | REL606 | 4,156,189 | 0 | T→C | 100.0% | 0.1 | 1 | 635 | tuf | protein chain elongation factor EF‑Tu (duplicate of tufA) |
* | REL606 | 4,156,200 | 0 | G→A | 100.0% | 0.1 | 1 | 646 | tuf | protein chain elongation factor EF‑Tu (duplicate of tufA) |
* | REL606 | 4,156,201 | 0 | A→C | 100.0% | 0.1 | 1 | 647 | tuf | protein chain elongation factor EF‑Tu (duplicate of tufA) |
* | REL606 | 4,156,206 | 0 | G→A | 100.0% | 0.1 | 1 | 652 | tuf | protein chain elongation factor EF‑Tu (duplicate of tufA) |
* | REL606 | 1,499,097 | 0 | A→C | 100.0% | ‑0.0 | 3 | 1014 | ECB_01413 | conserved hypothetical protein |
* | REL606 | 1,607,779 | 0 | A→C | 100.0% | ‑0.0 | 2 | 154 | ECB_01510 | putative tail component of prophage |
* | REL606 | 1,607,780 | 0 | G→A | 100.0% | ‑0.0 | 2 | 153 | ECB_01510 | putative tail component of prophage |
* | REL606 | 1,607,785 | 0 | G→A | 100.0% | 0.0 | 2 | 148 | ECB_01510 | putative tail component of prophage |
* | REL606 | 4,156,192 | 0 | T→C | 100.0% | 0.0 | 1 | 638 | tuf | protein chain elongation factor EF‑Tu (duplicate of tufA) |
* | REL606 | 4,156,208 | 0 | A→C | 100.0% | 0.0 | 1 | 654 | tuf | protein chain elongation factor EF‑Tu (duplicate of tufA) |
* | REL606 | 429,880 | 0 | T→G | 100.0% | ‑0.1 | 1 | 908 | insL‑2 | putative transposase insL for insertion sequence IS186 |
* | REL606 | 430,328 | 0 | C→T | 100.0% | ‑0.1 | 1 | 460 | insL‑2 | putative transposase insL for insertion sequence IS186 |
* | REL606 | 430,473 | 0 | A→C | 100.0% | ‑0.1 | 1 | 315 | insL‑2 | putative transposase insL for insertion sequence IS186 |